You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prostaglandin/timolol fixed combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Open-angle Glaucoma, Ocular Hypertension Trial in Zagreb (Switching the preserved prostaglandin analog-timolol FC to

Recruiting
  • Primary Open-angle Glaucoma
  • Ocular Hypertension
  • Switching the preserved prostaglandin analog-timolol FC to Fixalpost (preservative free prostaglandin analog-timolol FC)
  • Zagreb, Croatia
    Klinički bolnički centar Zagreb
May 13, 2021

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /

Completed
  • Ocular Surface Disease
  • Primary Open Angle Glaucoma
  • Tafluprost, timolol maleate
  • Taoyuan city, Taiwan
    Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022

Glaucoma Trial (Brimonidine/timolol fixed combination drops added to travoprost, Brinzolamide/timolol fixed combination drops

Completed
  • Glaucoma
  • Brimonidine/timolol fixed combination drops added to travoprost
  • Brinzolamide/timolol fixed combination drops added to travoprost
  • (no location specified)
Dec 16, 2020

Glaucoma Trial (treatment with latanoprost/timolol fixed combination, latanoprost/timolol fixed combination drops)

Completed
  • Glaucoma
  • treatment with latanoprost/timolol fixed combination
  • latanoprost/timolol fixed combination drops
  • (no location specified)
Dec 16, 2020

Glaucoma, Open-Angle Trial in Thessaloníki (Tafluprost/timolol fixed combination)

Completed
  • Glaucoma, Open-Angle
  • Tafluprost/timolol fixed combination
  • Thessaloníki, Makedonia, Greece
    1st University Department of Ophthalmology
Dec 16, 2020

Ocular Hypertension, Glaucoma, Open-angle Glaucoma Trial in Germany (i. Fixed combination of latanoprost 0.005% and timolol

Completed
  • Ocular Hypertension
  • +2 more
  • i. Fixed combination of latanoprost 0.005% and timolol 0.5%
  • +2 more
  • Aachen, Germany
  • +36 more
Feb 17, 2021

The Persistency Of Xalacom And The Other Fixed Dose Combination

Completed
  • Glaucoma
  • Ocular Hypertension
  • (no location specified)
Feb 1, 2021

Glaucoma, Ocular Surface Disease Trial (tafluprost, tafluprost and dorzolamide/timolol)

Completed
  • Glaucoma
  • Ocular Surface Disease
  • (no location specified)
Dec 16, 2020

Adherence With Fixed Versus Unfixed Glaucoma Therapy

Completed
  • Primary Open-angle Glaucoma
  • +2 more
    • Thessaloniki, Greece
      Glaucoma Unit, 1st University Department of Ophthalmology, AHEPA
    Dec 16, 2020

    Ocular Hypertension, Glaucoma Trial in United States (latanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5%)

    Completed
    • Ocular Hypertension
    • Glaucoma
    • latanoprost 0.005%
    • +2 more
    • Anaheim, California
    • +52 more
    Feb 17, 2021

    Glaucoma, Open Angle, Ocular Hypertension Trial in Worldwide (Xalacom, Cosopt)

    Completed
    • Glaucoma, Open Angle
    • Ocular Hypertension
    • Caen, France
    • +24 more
    Feb 17, 2021

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Milano, Pavia, Roma (tafluprost/timolol)

    Recruiting
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Milano, Italy
    • +2 more
    Mar 18, 2022

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)

    Recruiting
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Olivos, Buenos Aires, Argentina
    • +5 more
    May 10, 2023

    Glaucoma, Ocular Hypertension Trial in Italy (Xalacom)

    Completed
    • Glaucoma
    • Ocular Hypertension
    • Arezzo, Italy
    • +20 more
    Feb 17, 2021

    Open-angle Glaucoma, Ocular Hypertension Trial in Changsha, Shanghai (A preservative-free, a clear, colorless sterile aqueous

    Unknown status
    • Open-angle Glaucoma, Ocular Hypertension
    • A preservative-free, a clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost and 5.0mg of timolol in 1mL
    • A preservative-free, a clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost in 1mL
    • Changsha, China
    • +1 more
    Jun 16, 2020

    Glaucoma, Primary Open Angle (POAG), Ocular Hypertension Trial in France (GSS questionnaire, IOP, LATANOPROST 0.005% / TIMOLOL

    Completed
    • Glaucoma, Primary Open Angle (POAG)
    • Ocular Hypertension
    • GSS questionnaire
    • +3 more
    • Agen, France
    • +101 more
    Feb 17, 2021

    Pain Trial in Salt Lake City (Acetaminophen/Naproxen Sodium Fixed Combination, Naproxen Sodium, Acetaminophen)

    Not yet recruiting
    • Pain
    • Acetaminophen/Naproxen Sodium Fixed Combination
    • +3 more
    • Salt Lake City, Utah
      JBR Clinical Research LLC
    Feb 27, 2023

    Primary Open Angle Glaucoma, Ocular Hypertension Trial in Montemorelos (dorzolamide-timolol-brimonidine)

    Completed
    Has Results
    • Primary Open Angle Glaucoma
    • Ocular Hypertension
    • Montemorelos, Nuevo Leon, Mexico
      Instituto de la Visión. Hospital Universitario La Carlota. Unive
    Jun 6, 2019

    Orthodontic Pain Trial in Salt Lake City (Acetaminophen/Naproxen Sodium)

    Not yet recruiting
    • Orthodontic Pain
    • Acetaminophen/Naproxen Sodium
    • Salt Lake City, Utah
      JBR Clinical Research LLP
    Apr 25, 2023

    Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System

    Recruiting
    • Cataract
    • +2 more
    • Bimatoprost Implant System (High Dose)
    • +4 more
    • Glendale, Arizona
      Arizona Advanced Eye Research Institute
    Nov 8, 2023

    Glaucoma Trial in Indianapolis (fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution, fixed

    Completed
    Has Results
    • Glaucoma
    • fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution
    • fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution
    • Indianapolis, Indiana
      (unnamed)
    Apr 10, 2019

    Primary Open Angle Glaucoma Trial in Cheras (Latanoprost/Timolol)

    Unknown status
    • Primary Open Angle Glaucoma
    • Cheras, Wilayah Persekutuan Kuala Lumpur, Malaysia
      Universiti Kebangsaan Malaysia Medical Centre
    Sep 19, 2019

    Patients Who Received EGFR-TKI for the Treatment of NSCLC and Developed Paronychia (Affecting Fingernails, Toenails or Both)

    Recruiting
    • Patients Who Received EGFR-TKI for the Treatment of Non-small Cell Lung Cancer and Developed Paronychia (Affecting Fingernails, Toenails or Both)
    • Topical Timolol
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 14, 2023

    Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution

    Recruiting
    • Open Angle Glaucoma, Ocular Hypertension
    • STN1012600 ophthalmic solution 0.002%
    • STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
    • Aichi, Japan
    • +15 more
    Aug 16, 2022

    Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

    Recruiting
    • Bioequivalence
    • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
    • ADVAIR DISKUS® 500/50
    • Larissa, Thessaly, Greece
      BECRO Clinical Facility
    Aug 29, 2023